Bonus Biogroup (BONS) — Capital Reinvestment Ratio

Latest as of December 2008: 0.76x

Bonus Biogroup (BONS) has a Capital Reinvestment Ratio of 0.76x as of December 2008, meaning it reinvests 1% of its operating cash flow (ILA20.52 Million) in capital expenditures (ILA15.67 Million). See Bonus Biogroup balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.76x
Capex / Operating Cash Flow

Operating Cash Flow

ILA20.52 Million
ILA

Capital Expenditures

ILA15.67 Million
ILA

Data as of

Dec 2008
Most recent filing

Bonus Biogroup Capital Reinvestment Ratio (2008–2008)

This chart tracks Bonus Biogroup's Capital Reinvestment Ratio across 1 annual periods. Check BONS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Bonus Biogroup (2008–2008)

Year-by-year Capital Reinvestment Ratio for Bonus Biogroup from 2008 to 2008. For live market cap and broader valuation context, see BONS market cap.

Year Reinvestment Ratio Operating CF (ILA) Capital Expenditures YoY Change
2008 0.76x ILA20.52 Million ILA15.67 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow